Fibroblast
Chicago
About Fibroblast
Fibroblast offers a cloud-based practice management tool that facilitates online patient self-scheduling and instant cross-referrals. Fibroblast solves these problems by providing patients with the ability to self-schedule appointments, anytime and anywhere, using a cloud-based calendar; by automating appointment notifications; by providing analytics tools for providers to optimize their practices; and by creating a network of interconnected providers to seamlessly refer patients. All parties in health care win: providers’ margins widen because of increased patient flow and efficiencies; patients are more satisfied, empowered, and engaged in their own care; and payors win because engaged patients are more responsible patients, who are more likely to seek out cost-effective preventative care.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $2.9M
- Last round: Series Unknown (Jan 2018)
- Website: fibroblast.com
- Phone: 312-834-7864
Industries & Categories
Enterprise Software, Health Care, Information Technology, Medical
Social Profiles
Canonical: https://fsome.com/organization/fibroblast-159161 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.